Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

KID syndrome should be reclassified as an ectodermal dysplasia.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Sgk3 is essential for normal hair follicle growth and maintenance.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Itraconazole may cause low platelet and white blood cell counts.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Insulin therapy helped a man with autoimmune issues regrow his hair.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.